Shopping Cart

GalChimia at a glance

Founded in 2001, we have become Spain’s leader in synthetic organic chemistry. Our expert, dedicated team of chemists has found a productive outlet for their obsession with chemistry, providing custom synthesis, discovery chemistry, process development, and analytical services to clients worldwide. Over the last 16 years we have completed more than 1000 projects in the field of drug discovery and more than 50 projects in the field of process development. Biotechs are entering Phase I studies with products that we helped to shape and API manufacturers supply products using processes we have developed.

Founded in 2001, we have become Spain’s leader in synthetic organic chemistry. Our expert, dedicated team of chemists has found a productive outlet for their obsession with chemistry, providing custom synthesis, contract research, process development, and analytical services to clients worldwide. Over the last 14 years we have completed more than 1000 projects in the field of drug discovery and more than 50 projects in the field of process development. Biotechs are entering Phase I studies with products that we helped to shape and API manufacturers supply products using processes we have developed.

2001

Carme and Jacobo, two young PhDs from the Department of Chemistry at the University of Santiago de Compostela, decided to start a pioneering venture in the field of chemical synthesis and GalChimia was born.

Our company was rated as an “Initiative for Technology-Based Employment” to acknowledge its application of high-level scientific knowledge.

UNIRISCO Galicia invested in our company and became part of the capital stockholders.

2002

BIC Galicia credited GalChimia as EIBT (a Technology-Based Innovative Company) to acknowledge the level of scientific expertise of its services.

IGAPE included Galchimia within the Lanza Project, supporting us with advice and specialised technical assistance.

We ended the year by being awarded UNIEMPRENDE for the best technology-based ideas.

2003

GalChimia attended the International Congress on Pharmaceutical Ingredients (CPhI Worldwide), held that year in Frankfurt, for the first time GalChimia received the “Ideas Mª José Jove” award from the Foundation “A Modern Galicia”.

2004

We changed our look! We renewed our logo and corporate colours, but our values, dedication and enthusiasm were still the same, or even greater, than when we began our activity.

This year we went to Brussels to attend CPhl-ICSE again.

We had our first 10 employees.

2005

GalChimia published the “Short Guide to Heterocycles” for the worldwide chemical community.

We sponsored the 14th National Congress of the Spanish Society of Therapeutic Chemistry and the 30th Biennial Meeting of the RSEQ.

2006

GalChimia was selected together with 20 other companies to participate in the “Accel” programme, which aims to accelerate technology-based companies.

GalChimia started the Genius Pharma consortium (supported by CENIT), together with Almirall, Esteve, Uriach, CrystaX and Enantia.

It was our fifth anniversary! We celebrated it with all our customers and friends in a successful Open Day so they could visit our facilities.

Then there were 15 of us on the staff!

2007

We continued attending and/or sponsoring the most important meetings, conferences and congresses in the world of chemistry, like the “2007 Synthetic Heterocyclic Chemistry Conference” or CPhl Biofine-ICSE.

This year GalChimia was the runner-up in the eighth edition of the AMJE Awards to acknowledge it being one of the best business initiatives of young entrepreneurs in the province of A Coruña.

We are now 24 employees thanks to our customers of course.

2008

Our newsletter “GalChimia Letters” was born: a pleasant, efficient way of keeping up-to-date on the latest publications and developments in the field of chemical synthesis. This year we attended Bio San Diego (California) 2008, and the journal “Tetrahedron Letters” published our article “Microwave-assisted aza-Cope rearrangement of N-allylanilines”.

GalChimia received the innovation award in the “IV edición de los Premios Transfronterizos a la Excelencia Empresarial”.

GalChimia was included among the 50 selected companies in the 10th anniversary issue of the journal “Drug Discovery & Development”.

2009

GalChimia attended BIO-Europe Spring 2009, a leading biotechnology congress in Europe. This year, as an exhibitor, we also attended the conference “Frontiers in Medicinal Chemistry” at the University of Heidelberg (Germany).

We published a new scientific paper, this time in the journal “Organic Letters”.

2010

This year we started with the GalChimia selection as a service provider for the NEOGENIUS project (supported by CENIT).

This year we attended BIO-Europe Spring, CPhI and ICSE Paris as an exhibitor.

We renewed our website by giving it a more modern image and with more information.

We achieved 100 completed projects with a success rate above 92%.

Carme Pampín, co-founder and CEO of GalChimia, was named president of the Galician Life Science biocluster BIOGA.

2011

As we do every year, we attended CPhl-ICSE, this time in Frankfurt..

We signed a partnership agreement with HQL Pharmaceuticals (Israel) for the research and development of molecules with potential therapeutic use in oncology, and also with the Portuguese company Alfama for the research and development of new pharmaceutical products for medical use and health care.

2012

GalChimia participated in the HUMANFARMA project, together with Vivia Biotech, Vivia Allosterics, Oryzon Genomics, the University of Santiago de Compostela (USC) and the Barcelona Science Park (PCB).

We celebrated our tenth anniversary.

GalChimiApplus was born, from the successfull colaboration between APPLUS in Barcelona and GalChimia in Galicia.

2013

GalChimia expanded its business including Pharmaceutical and Agrochemical Standards.

We have completed more than 500 projects and 30 Drug Discovery Process Developments in collaboration with international reference customers in the biopharmaceutical sector.

2014

This year we started an European projects called HotDrops aiming at the development of new industrial enzymes.

GalChimia incorporated an international business developer.

GalChimia was also accredited with the CIR (Crédit d’Impôt Recherche) by the French Government, highlighting the involvement of the company in R&D projects.

We also attended RICT (International Conference on Medicinal Chemistry) and CPhI.

2015

We are part of the Nanofacturing consorcium, a Horizon 2020 project based on nanotechnology.

Our diversification is increasing and we are starting to work actively with agrochemical companies.

We signed our first contract research contract with a US company.

Our catalogue of products is increasing, overtaking 100 products.

2016

After France and Belgium GalChimia is focusing on Germany and UK for its international development.

First assistance to the ACS conference in Philadelphia.

The company is still active in oncology drug discovery and starts the Neogalfarm, representing the phase 2 of the project Oncogalfarm initiated in 2014.

2017

Establishment of long term collaborations with French and German pharmaceutical companies.

Elaboration of GalChimia’s Environmental Policy.

Increase of discovery chemistry activity.

GalChimia celebrates its 15th anniversary

*Click on the year to find out about the main milestones in our history.

2001

Carme and Jacobo, two young PhDs from the Department of Chemistry at the University of Santiago de Compostela, decided to start a pioneering venture in the field of chemical synthesis and GalChimia was born.

Our company was rated as an “Initiative for Technology-Based Employment” to acknowledge its application of high-level scientific knowledge.

UNIRISCO Galicia invested in our company and became part of the capital stockholders.

2002

BIC Galicia credited GalChimia as EIBT (a Technology-Based Innovative Company) to acknowledge the level of scientific expertise of its services.

IGAPE included Galchimia within the Lanza Project, supporting us with advice and specialised technical assistance.

We ended the year by being awarded UNIEMPRENDE for the best technology-based ideas.

2003

GalChimia attended the International Congress on Pharmaceutical Ingredients (CPhI Worldwide), held that year in Frankfurt, for the first time GalChimia received the “Ideas Mª José Jove” award from the Foundation “A Modern Galicia”.

2004

We changed our look! We renewed our logo and corporate colours, but our values, dedication and enthusiasm were still the same, or even greater, than when we began our activity.

This year we went to Brussels to attend CPhl-ICSE again.

We had our first 10 employees.

2005

GalChimia published the “Short Guide to Heterocycles” for the worldwide chemical community.

We sponsored the 14th National Congress of the Spanish Society of Therapeutic Chemistry and the 30th Biennial Meeting of the RSEQ.

2006

GalChimia was selected together with 20 other companies to participate in the “Accel” programme, which aims to accelerate technology-based companies.

GalChimia started the Genius Pharma consortium (supported by CENIT), together with Almirall, Esteve, Uriach, CrystaX and Enantia.

It was our fifth anniversary! We celebrated it with all our customers and friends in a successful Open Day so they could visit our facilities.

Then there were 15 of us on the staff!

2007

We continued attending and/or sponsoring the most important meetings, conferences and congresses in the world of chemistry, like the “2007 Synthetic Heterocyclic Chemistry Conference” or CPhl Biofine-ICSE.

This year GalChimia was the runner-up in the eighth edition of the AMJE Awards to acknowledge it being one of the best business initiatives of young entrepreneurs in the province of A Coruña.

We are now 24 employees thanks to our customers of course.

2008

Our newsletter “GalChimia Letters” was born: a pleasant, efficient way of keeping up-to-date on the latest publications and developments in the field of chemical synthesis. This year we attended Bio San Diego (California) 2008, and the journal “Tetrahedron Letters” published our article “Microwave-assisted aza-Cope rearrangement of N-allylanilines”.

GalChimia received the innovation award in the “IV edición de los Premios Transfronterizos a la Excelencia Empresarial”.

GalChimia was included among the 50 selected companies in the 10th anniversary issue of the journal “Drug Discovery & Development”.

2009

GalChimia attended BIO-Europe Spring 2009, a leading biotechnology congress in Europe. This year, as an exhibitor, we also attended the conference “Frontiers in Medicinal Chemistry” at the University of Heidelberg (Germany).

We published a new scientific paper, this time in the journal “Organic Letters”.

2010

This year we started with the GalChimia selection as a service provider for the NEOGENIUS project (supported by CENIT).

This year we attended BIO-Europe Spring, CPhI and ICSE Paris as an exhibitor.

We renewed our website by giving it a more modern image and with more information.

We achieved 100 completed projects with a success rate above 92%.

Carme Pampín, co-founder and CEO of GalChimia, was named president of the Galician Life Science biocluster BIOGA.

2011

As we do every year, we attended CPhl-ICSE, this time in Frankfurt..

We signed a partnership agreement with HQL Pharmaceuticals (Israel) for the research and development of molecules with potential therapeutic use in oncology, and also with the Portuguese company Alfama for the research and development of new pharmaceutical products for medical use and health care.

2012

GalChimia participated in the HUMANFARMA project, together with Vivia Biotech, Vivia Allosterics, Oryzon Genomics, the University of Santiago de Compostela (USC) and the Barcelona Science Park (PCB).

We celebrated our tenth anniversary.

GalChimiApplus was born, from the successfull colaboration between APPLUS in Barcelona and GalChimia in Galicia.

2013

GalChimia expanded its business including Pharmaceutical and Agrochemical Standards.

We have completed more than 500 projects and 30 Drug Discovery Process Developments in collaboration with international reference customers in the biopharmaceutical sector.

2014

This year we started an European projects called HotDrops aiming at the development of new industrial enzymes.

GalChimia incorporated an international business developer.

GalChimia was also accredited with the CIR (Crédit d’Impôt Recherche) by the French Government, highlighting the involvement of the company in R&D projects.

We also attended RICT (International Conference on Medicinal Chemistry) and CPhI.

2015

We are part of the Nanofacturing consorcium, a Horizon 2020 project based on nanotechnology.

Our diversification is increasing and we are starting to work actively with agrochemical companies.

We signed our first contract research contract with a US company.

Our catalogue of products is increasing, overtaking 100 products.

2016

After France and Belgium GalChimia is focusing on Germany and UK for its international development.

First assistance to the ACS conference in Philadelphia.

The company is still active in oncology drug discovery and starts the Neogalfarm, representing the phase 2 of the project Oncogalfarm initiated in 2014.

2017

Establishment of long term collaborations with French and German pharmaceutical companies.

Elaboration of GalChimia’s Environmental Policy.

Increase of discovery chemistry activity.

GalChimia celebrates its 15th anniversary

*Click on the year to find out about the main milestones in our history.